Physician profile
Marlene Hall
NPI 1942603584
$1,535.98
in general payments reported to CMS, 2019-2025
20 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $374 · 2022: $246 · 2023: $154 · 2024: $405 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $390.47 | 2022-2025 | Impella |
| Glaxosmithkline, LLC. | $325.70 | 2022-2025 | Nucala |
| Atricure, INC. | $144.17 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $130.52 | 2021-2024 | Sapien 3 Ultra Resilia |
| Kci USA, INC. | $106.30 | 2021 | |
| La Jolla Pharmaceutical Company | $52.34 | 2024-2025 | Giapreza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $46.94 | 2021-2024 | Andexxa |
| Haemonetics Corporation | $42.97 | 2025 | Teg6s Hemostasis System |
| Alexion Pharmaceuticals, INC. | $41.71 | 2022 | |
| Mindray Ds USA, INC. | $37.30 | 2024 | Te7 Max, Te X |
| Gilead Sciences, INC. | $25.28 | 2021 | |
| Medtronic, INC. | $24.64 | 2024 | Azure Xt Dr Mri Surescan |
| Cardiva Medical, INC. | $24.20 | 2025 | Cardiva Vascade 6/7f Vcs |
| Smith+Nephew, INC. | $17.82 | 2024 | Collagenase Santyl |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $17.71 | 2024 | Prevena, V.A.C.Ulta |
| Abbvie INC. | $16.22 | 2021 | |
| Avanos Medical | $15.58 | 2025 | Cortrak |
| Amgen INC. | $14.46 | 2021 | |
| Csl Behring | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.